↓ Skip to main content

ASSURE‐CSU: a real‐world study of burden of disease in patients with symptomatic chronic spontaneous urticaria

Overview of attention for article published in Clinical and Translational Allergy, August 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
10 X users
facebook
1 Facebook page

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
68 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
ASSURE‐CSU: a real‐world study of burden of disease in patients with symptomatic chronic spontaneous urticaria
Published in
Clinical and Translational Allergy, August 2015
DOI 10.1186/s13601-015-0072-9
Pubmed ID
Authors

Karsten Weller, Marcus Maurer, Clive Grattan, Alla Nakonechna, Mohamed Abuzakouk, Frédéric Bérard, Gordon Sussman, Ana M. Giménez-Arnau, Javier Ortiz de Frutos, André Knulst, G. Walter Canonica, Kelly Hollis, Doreen McBride, Maria-Magdalena Balp

Abstract

Chronic spontaneous urticaria (CSU) formerly known as chronic idiopathic urticaria (CIU) is a severe and distressing skin condition that remains uncontrolled in approximately one half of patients, despite the use of licensed, recommended doses of modern, second-generation H1-antihistamines. So far, the humanistic, societal and economic burden of CSU/CIU has not been well quantified. Therefore it is important to broaden our understanding of how CSU/CIU impacts patients, society, and healthcare systems, by determining the disease burden of CSU/CIU and the associated unmet need; as well as to further guide the use of new treatments in an efficient and cost-effective manner. ASSURE-CSU is an observational, multicenter study being conducted in the UK, Germany, Canada, France, Italy, Spain, and The Netherlands. The study comprises a retrospective medical chart review in conjunction with patient surveys (including validated tools for assessment of disease impact) and an 8-day patient diary. The primary objectives of the study are to describe patient demographics, medical history, treatments, and healthcare resource utilization based on medical-record data and to assess the impact of disease, healthcare resource utilization, work days missed, and productivity loss based on patient-reported data. Approximately 700 patients (aged ≥18 years) will be enrolled who have CSU/CIU despite currently receiving treatment, and have had persistent symptoms for at least 12 months. Data will be collected retrospectively for the 12 months (±1 month) prior to enrolment wherever possible, and prospectively for the week following enrolment. ASSURE-CSU will be the first study to examine the economic and humanistic burden of disease in patients diagnosed with CSU/CIU who are symptomatic despite treatment. By combining retrospective evaluation of medical records with prospective patient surveys and 8-day diaries, across seven different countries, the ASSURE-CSU study will contribute to a better understanding and acknowledgement of the burden of disease in patients with symptomatic chronic spontaneous urticaria.

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 68 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Korea, Republic of 1 1%
United States 1 1%
Unknown 66 97%

Demographic breakdown

Readers by professional status Count As %
Other 12 18%
Student > Master 8 12%
Researcher 8 12%
Student > Postgraduate 5 7%
Student > Ph. D. Student 4 6%
Other 9 13%
Unknown 22 32%
Readers by discipline Count As %
Medicine and Dentistry 24 35%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Neuroscience 3 4%
Agricultural and Biological Sciences 3 4%
Nursing and Health Professions 2 3%
Other 9 13%
Unknown 24 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 April 2016.
All research outputs
#5,429,287
of 25,374,917 outputs
Outputs from Clinical and Translational Allergy
#329
of 756 outputs
Outputs of similar age
#63,551
of 277,790 outputs
Outputs of similar age from Clinical and Translational Allergy
#6
of 11 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 756 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.7. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,790 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 11 others from the same source and published within six weeks on either side of this one. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.